FDA Archives - Page 16 of 24

KHN’s ‘What the Health?’: It’s Scandal Week

President Donald Trump this week issued a prescription drug pricing order unlikely to lower drug prices, and he contradicted comments by his director of the Centers for Disease Control and Prevention on the need for mask-wearing and predictions for vaccine availability. Meanwhile, scandals erupted at the CDC, the Centers for Medicare & Medicaid Services and the Food and Drug Administration. And the number of people without health insurance grew in 2019, reported the Census Bureau, even while the economy soared. Alice Miranda Ollstein of Politico, Tami Luhby of CNN and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss this and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.

Sept. 17, 2020

Podcast

KHN’s ‘What the Health?’: The Politics of Science

Republicans have all but abandoned the Affordable Care Act as a campaign cudgel, judging from their national convention, at least. Meanwhile, career scientists at the federal government’s preeminent health agencies — the Food and Drug Administration, the Centers for Disease Control and Prevention and the National Institutes of Health — are all coming under increasing political pressure as the pandemic drags on. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss this and more. Plus, Rovner interviews KHN’s Elizabeth Lawrence about the latest KHN-NPR “Bill of the Month” installment.

Sept. 10, 2020

COVID-19

Most Adults Wary of Taking Any Vaccine Approved Before the Election

About 60% of poll respondents are worried that federal regulators will rush to allow a vaccine because of political pressure. Opposition to getting a vaccine that might be authorized before the November election is strongest among Republicans.

By Jordan Rau

Sept. 10, 2020

COVID-19

Dozens of U.S. Hospitals Poised to Defy FDA’s Directive on COVID Plasma

The FDA, under pressure from the Trump administration, has authorized broader use of convalescent plasma for emergency treatment in COVID patients. But several major hospitals are resisting, saying they’ll opt instead to use the scarce resource to complete a clinical trial.

By JoNel Aleccia

Sept. 3, 2020

COVID-19

5 Things to Know About Convalescent Blood Plasma

President Donald Trump touted the Food and Drug Administration’s approval of this unproven COVID-19 treatment for emergency use. That set off reactions ranging from excitement and optimism to scientific concerns and criticism that the decision was politically motivated.

By Victoria Knight

Aug. 27, 2020

COVID-19

Trump Is Sending Fast, Cheap COVID Tests to Nursing Homes — But There’s a Hitch

Experts say the administration’s approach with antigen tests could add cost and risk for the most vulnerable patients.

By Rachana Pradhan

Aug. 24, 2020

KHN & PolitiFact HealthCheck

Don’t Fall for This Video: Hydroxychloroquine Is Not a COVID-19 Cure

This statement is taken from a video in which a group of doctors air unproven conspiracy theories about the coronavirus. Dr. Immanuel's claims were among the most inaccurate. And, before it was removed from social media platforms, thee video was viewed millions of times. President Donald Trump retweeted it.

By Daniel Funke, PolitiFact

July 31, 2020

COVID-19

Public Health Experts Fear a Hasty FDA Signoff on Vaccine

The FDA must approve any coronavirus vaccine before it’s widely distributed, but political pressure could cloud the decision.

By Arthur Allen

July 29, 2020

Podcast

KHN’s ‘What The Health?’: Trump Twists on Virus Response

President Donald Trump has, for now at least, become a realist on the extent of the COVID-19 crisis around the country, and he is urging Americans to socially distance and wear masks. Meanwhile, on Capitol Hill, Republicans facing a July 31 deadline are scrambling to come together on their version of the next COVID relief bill. Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Tami Luhby of CNN join KHN’s Julie Rovner to discuss this and more. Also, Rovner interviews NPR’s Pam Fessler, author of the new book “Carville’s Cure,” which traces the history of the United States’ only federal leprosarium.

July 23, 2020

COVID-19

Pandemic-Inspired Food Labeling Raises Alarms for Those With Food Allergies

The Food and Drug Administration released new “temporary guidance” for manufacturers facing supply chain shortages that allows them to make some ingredient substitutions without changing food labels. The pandemic had already made finding trusted foods difficult for some people with allergies. Now they're worrying about what's actually in their go-to products.

By Sandy West

July 21, 2020

How Mis- And Disinformation Campaigns Online Kneecap Coronavirus Response

The pandemic has been marked by a significant amount of misinformation — some spread on purpose — that could prove deadly.

By Shefali Luthra

June 29, 2020

COVID-19

As Problems Grow With Abbott’s Fast COVID Test, FDA Standards Are Under Fire

After the FDA issues a public warning about the test, one of its senior officials says point-of-care coronavirus tests can miss 20% of cases and still be considered useful. Public health experts are split.

By Rachana Pradhan

June 22, 2020

Easy To Say ‘Get Tested.’ Harder To Do. Here’s How.

If you’ve been in a crowd — a protest or rally — experts have advice for figuring out whether you might have been exposed to the coronavirus, and where and when to get tested for it.

By Bernard J. Wolfson and Phil Galewitz

June 22, 2020

Podcast

KHN’s ‘What the Health?’: SCOTUS, Trump Collide Over Transgender Rights

The Trump administration rolled back protections for transgender patients just days before the Supreme Court cemented LGBTQ rights under the Civil Rights Act. So, what now? Meanwhile, coronavirus politics reaches beyond health care settings. Anna Edney of Bloomberg News, Tami Luhby of CNN and Shefali Luthra of KHN join KHN’s Julie Rovner to discuss this and more. Also, for extra credit, the panelists recommend their favorite health stories of the week they think you should read, too.

June 18, 2020

COVID-19

Hype Collides With Science As FDA Tries To Rein In ‘Wild West’ of COVID Blood Tests

Amid questions about the accuracy of the COVID-19 antibody tests flooding the market — and the usefulness of the results they provide — the FDA has belatedly stepped in to try to rein in the chaos.

By JoNel Aleccia and Anna Maria Barry-Jester

June 3, 2020

COVID-19

Antibody Tests Were Hailed As Way To End Lockdowns. Instead, They Cause Confusion.

Some communities considered community antibody testing as a way out of lockdown. But they've pulled back as they realized antibody testing is the Wild West in an oversight vacuum.

By Christie Aschwanden

May 28, 2020

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.

By Brianna Labuskes

May 8, 2020

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.

By Brianna Labuskes

April 24, 2020

COVID-19

Abbott’s Fast COVID Test Poses Safety Issues, Lab Workers Say

HHS said this test would “save personal protective equipment.” But Abbott’s very design ― devised for mobile testing — means those working with specimens need even more protection, experts warn.

By Rachana Pradhan

April 23, 2020